arrow
D

Dorairaj Prabhakaran

centre for chronic disease control
H指数:107
被引数:13.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Triple drug antihypertensive single-pill combinations included as WHO essential medicines: an overview of efficacy, safety, and cost

WHO基本药物中包含的三联降压单片复方制剂:疗效、安全性与成本概述

2026-08-130
PRE
Exploring the mechanisms of yoga-based cardiac rehabilitation in heart failure via assessment of endothelial function, genomics and arterial health (Yoga-EndOmics): a study protocol

通过评估内皮功能、基因组学和动脉健康来探讨基于瑜伽的心脏康复在心力衰竭中的机制(Yoga-EndOmics):一项研究方案

2026-01-130
OA
Does health insurance coverage improve cardiometabolic risk factor levels? Quasi-experimental evidence from India

健康保险覆盖是否改善了心血管代谢风险因素水平?来自印度的准实验证据

2025-12-310
PRE
Exercise-based cardiac rehabilitation for coronary heart disease: the CaReMATCH individual participant data meta-analysis

基于运动的冠心病心脏康复:CaReMATCH个体参与者数据Meta分析

2025-10-010
PRE
Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial

印度高血压治疗中两种联合疗法的比较:一项随机临床试验

2025-07-250
OA
Synergistic associations of ambient air pollution and heat on daily mortality in India

印度环境中空气污染与高温对每日死亡率的协同作用关联

2025-05-010
OAAI
International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations eGFR epidemiology (DEGREE) study

基于人口为基础的横断面弱势人群eGFR流行病学(DEGREE)研究,18-60岁无传统危险因素成人低eGFR的国际患病率模式。

2025-03-011
OAAI
Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19-20 and WHF COVID-19 CVD Studies
2025-01-010
OAAI
Nationwide analysis of air pollution hotspots across India: A spatiotemporal PM2.5 trend analysis (2008-2019)

印度全国空气污染热点分析: 时空PM2.5趋势分析 (2008-2019)

2025-01-010
OAAI